Kyndryl
KD NYSE IT Consulting & Other Services Financials FY2019βFY2026
Kyndryl's revenue rose 0.2% to $15.1 billion in fiscal 2026. Its net margin was 1.3%, down from 1.7% a year earlier. Free cash flow was $340 million, up 0.9%. It paid out $304 million in dividends and buybacks, 89% of free cash flow. The diluted share count fell 2.2%.
What Kyndryl does
No business description yet.
- Legal name
- Kyndryl Holdings, Inc.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001104659-26-067881
0001867072
Revenue and margins
Kyndryl had $15.1B of revenue in fiscal 2026, up 0.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $340M in fiscal 2026, 2.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Kyndryl returned $304M to shareholders in fiscal 2026, 89% of free cash flow. The diluted share count fell 2.2%.
Value Kyndryl yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.3B and divides by 233.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 39.9x Β· peers 21.0x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Kyndryl can carry it.
| Fiscal year end | FY21 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.2B | $1.8B | $1.6B | $1.8B | $2.6B |
| Debt incl. finance leases | $3.4B | $3.3B | $3.4B | $3.3B | $4.9B |
| Net debt / EBITDA | β | 7.9x | 2.2x | 1.3x | 1.8x |
| Debt / equity | 1.2x | 2.5x | 3.3x | 2.7x | 4.2x |
| Interest coverage | β28.7x | β8.1x | β0.4x | 5.4x | 5.7x |
| Current ratio | 1.3x | 1.0x | 1.0x | 1.1x | 0.9x |
| Quick ratio | 1.3x | 1.0x | 1.0x | 1.1x | 0.9x |
| Total assets | $13.2B | $11.5B | $10.6B | $10.5B | $12.6B |
| Total liabilities | $10.4B | $10.0B | $9.5B | $9.1B | $11.3B |
| Shareholders' equity | $2.8B | $1.4B | $1.0B | $1.2B | $1.2B |
| Net debt (β = net cash) | $1.1B | $1.5B | $1.8B | $1.5B | $2.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.2M
1 insider
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 5, 2025 | Vineet KhuranaSVP & Global Controller | Sold | 6,641 | $26.69 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | 7 / 9 | 6 / 9 |
| Accruals ratio | β7.2% | β6.6% | β6.5% |
| Altman Z'' | β0.52 | 0.03 | β0.50 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Kyndryl KD | $3.3B | 0.2% | β | 2.3% | 7.8% | 39.9x | 6 | |
| DXC Technology DXC | $2.7B | β1.8% | 7.7% | 8.2% | 9.2% | 21.2x | 7 | Compare β |
| Cognizant CTSH | $33.6B | 7.0% | 16.1% | 12.3% | 16.2% | 15.3x | 6 | Compare β |
| Gartner IT | $15.3B | 3.7% | 15.8% | 18.1% | 44.6% | 20.8x | 5 | Compare β |
| IBM IBM | $241.8B | 7.6% | β | 17.9% | 15.4% | 21.6x | 6 | Compare β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $20.3B | $19.4B | $18.7B | $17.0B | $16.1B | $15.1B | $15.1B |
| Gross profit | $2.6B | $2.2B | $2.1B | $2.5B | $2.9B | $3.1B | $3.3B |
| Research and development | $83.0M | $76.0M | $63.0M | $79.0M | $58.0M | $49.0M | $57.0M |
| Interest expense | $76.0M | $63.0M | $64.0M | $94.0M | $122M | $100M | $89.0M |
| Pretax income | β$579M | β$1.8B | β$1.9B | β$851M | β$168M | $435M | $414M |
| Income tax | $364M | $247M | $402M | $524M | $172M | $184M | $215M |
| Net income | β$943M | β$2.0B | β$2.3B | β$1.4B | β$340M | $252M | $198M |
| Diluted EPS | β$4.21 | β$8.96 | β$10.28 | β$6.06 | β$1.48 | $1.05 | $0.85 |
| Diluted shares | 0.22B | 0.22B | 0.22B | 0.23B | 0.23B | 0.24B | 0.23B |
| Cash flow | |||||||
| Cash from operations | $1.1B | $628M | β$119M | $781M | $454M | $942M | $948M |
| Capital expenditure | $1.2B | $1.0B | $752M | $865M | $651M | $605M | $608M |
| Free cash flow | β$56.0M | β$408M | β$871M | β$84.0M | β$197M | $337M | $340M |
| Depreciation and amortization | $1.5B | $1.5B | $1.3B | $946M | $864M | $690M | $789M |
| Stock-based compensation | $51.0M | $64.0M | $71.0M | $113M | $95.0M | $100M | $64.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $93.0M | $304M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $93.0M | $304M |
| Balance sheet | |||||||
| Cash and short-term investments | $50.0M | $24.0M | $2.2B | $1.8B | $1.6B | $1.8B | $2.6B |
| Total debt | β | $278M | $3.4B | $3.3B | $3.4B | $3.3B | $4.9B |
| Finance lease liabilities | $0.0M | $209M | $223M | $242M | $288M | $250M | $194M |
| Current assets | β | $2.8B | $5.8B | $5.0B | $4.7B | $4.6B | $5.5B |
| Current liabilities | β | $3.9B | $4.5B | $4.9B | $4.6B | $4.3B | $6.3B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | β | $4.0B | $2.9B | $2.8B | $2.7B | $2.6B | $2.5B |
| Total assets | β | $11.2B | $13.2B | $11.5B | $10.6B | $10.5B | $12.6B |
| Total liabilities | β | $6.3B | $10.4B | $10.0B | $9.5B | $9.1B | $11.3B |
| Shareholders' equity | $6.0B | $4.9B | $2.8B | $1.4B | $1.0B | $1.2B | $1.2B |
| Margins | |||||||
| Gross margin | 12.8% | 11.5% | 11.3% | 14.9% | 17.8% | 20.9% | 21.8% |
| EBITDA margin | 4.9% | β1.2% | β2.7% | 1.1% | 5.1% | 8.1% | 8.6% |
| Net margin | β4.7% | β10.4% | β12.4% | β8.1% | β2.1% | 1.7% | 1.3% |
| FCF margin | β0.3% | β2.1% | β4.7% | β0.5% | β1.2% | 2.2% | 2.3% |
| Returns | |||||||
| Return on capital | β | β | β31.8% | β | β1.2% | 10.6% | 7.8% |
| Return on capital employed | β | β | β22.9% | β | β0.7% | 8.8% | 8.1% |
| Return on equity | β | β | β60.3% | β | β28.6% | 22.6% | 16.5% |
| Return on assets | β | β | β18.9% | β | β3.1% | 2.4% | 1.7% |
| Growth | |||||||
| Revenue growth | β | β4.6% | β3.6% | β | β5.7% | β6.2% | 0.2% |
| Net income growth | β | β | β | β | β | β | β21.4% |
| EPS growth | β | β | β | β | β | β | β19.1% |
| FCF growth | β | β | β | β | β | β | 0.9% |
| Share count change | β | 0.0% | 0.0% | β | 1.1% | 4.3% | β2.2% |
| Financial health | |||||||
| Net debt / EBITDA | β | β | β | 7.9x | 2.2x | 1.3x | 1.8x |
| Debt / equity | β | 0.1x | 1.2x | 2.5x | 3.3x | 2.7x | 4.2x |
| Interest coverage | β6.6x | β26.9x | β28.7x | β8.1x | β0.4x | 5.4x | 5.7x |
| Current ratio | β | 0.7x | 1.3x | 1.0x | 1.0x | 1.1x | 0.9x |
| Quick ratio | β | 0.7x | 1.3x | 1.0x | 1.0x | 1.1x | 0.9x |
| Capital allocation | |||||||
| Capex / revenue | 5.9% | 5.4% | 4.0% | 5.1% | 4.1% | 4.0% | 4.0% |
| Stock comp / revenue | 0.3% | 0.3% | 0.4% | 0.7% | 0.6% | 0.7% | 0.4% |
| Payouts / FCF | β | β | β | β | β | 27.6% | 89.4% |
| Quality scores | |||||||
| Piotroski F-score | β | β | β | β | β | 7.0 | 6.0 |
| Altman Z'' | β | β | β0.1 | β0.8 | β0.5 | 0.0 | β0.5 |
| Accruals ratio | β | β | β17.9% | β | β7.2% | β6.6% | β6.5% |
Source: SEC EDGAR XBRL filings (CIK 0001867072). Data updated October 12, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.